WuXi AppTec Co., Ltd.

All Holdings — 2024 Q3

AI Portfolio Summary
In 2024 Q3, WuXi AppTec Co., Ltd. maintained a portfolio of 2 distinct positions. The fund also reduced its exposure to LYELL IMMUNOPHARMA I by 3.8%.
PCA Score Concentration Risk
Risk ENB
Total Positions
2
Quarter
2024 Q3
Top Holding
LYEL (53.6%)
Top 10 Concentration
100.0%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-2 of 2
Stock History Sector / Type Port % Prev % Rank / Prev Conviction Change % Change Influence Shares Mkt Value Avg Cost Price Held 1st Owned Source Source Date Date Reported
LYEL
LYELL IMMUNOPHA...
Healthcare 53.56% 47.74% #1 1
Prev: #2
10.0 -291,446 -3.8%
P
S
7,390,710 $10,199,180,000 2023 Q4 13F Filing 2024-09-30 2024-11-14 (Est.)
ADAG
ADAGENE INC
Healthcare 46.44% 52.26% #2 1
Prev: #1
10.0 no change no change
P
S
3,982,902 $8,842,042,000 2023 Q4 13F Filing 2024-09-30 2024-11-14 (Est.)
Showing 1-2 of 2 holdings

Unlock Full WuXi AppTec Co., Ltd. Analysis

PRO subscribers get access to all historical quarters, Excel/CSV exports, Portfolio Concentration Analytics (PCA), and Risk-Based ENB.

Full Historical Quarters
Excel & CSV Export
PCA & Risk-Based ENB
Auto Cost Basis
Position Change Alerts
Price-Held Analytics